Kazia Therapeutics Appoints James Levine as Chief Financial Officer
Go back to Kazia Therapeutics Appoints James Levine as Chief Financial Officer| (NASDAQ: KZIA) | Delayed: 9.76 -0.02 (0.2%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.78 | 52 Week High | $ | |||
| Open | $9.77 | 52 Week Low | $ | |||
| Day High | $9.99 | P/E | N/A | |||
| Day Low | $9.60 | EPS | $ | |||
| Volume | 76,144 | |||||

